A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia

NCT06900920 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

199

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Immune Thrombocytopenia

Interventions

DRUG: TQB3473 Tablets
DRUG: TQB3473 Placebo

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.